Crystalline forms of pitavastatin calcium
    2.
    发明申请
    Crystalline forms of pitavastatin calcium 审中-公开
    匹伐他汀钙的结晶形式

    公开(公告)号:US20060142582A1

    公开(公告)日:2006-06-29

    申请号:US10544752

    申请日:2004-02-02

    IPC分类号: C07D215/16

    CPC分类号: C07D215/14 C07B2200/13

    摘要: The present invention is directed to new crystalline forms of Pitavastatin hernicalcium salt, referred to hereinafter as polymorphic Forms A, B, C, D, E and F, as well as the amorphous form. Furthermore, the present invention is directed to processes for the preparation of these crystalline forms and the amorphous form and pharmaceutical compositions comprising these crystalline forms or the amorphous form.

    摘要翻译: 本发明涉及匹伐他汀鞣酸盐的新结晶形式,以下称为多晶型A,B,C,D,E和F,以及无定形形式。 此外,本发明涉及制备这些结晶形式的方法和包含这些结晶形式或无定形形式的无定型形式和药物组合物。

    Crystalline forms of atorvastatin
    5.
    发明申请
    Crystalline forms of atorvastatin 审中-公开
    阿托伐他汀的结晶形式

    公开(公告)号:US20060205805A1

    公开(公告)日:2006-09-14

    申请号:US11431184

    申请日:2006-05-09

    IPC分类号: A61K31/401 C07D207/337

    CPC分类号: C07D207/34

    摘要: The present invention is directed to new crystalline forms of Atorvastatin calcium (2:1), referred to hereinafter as polymorphic Forms X, A, B1, B2, C, D and E. The present invention also is directed to crystalline Form A of Atorvastatin calcium (2:1) that is stable against the formation of the AED impurity. Furthermore, the present invention is directed to processes for the preparation of these crystalline forms and pharmaceutical compositions comprising the crystalline forms.

    摘要翻译: 本发明涉及阿托伐他汀钙(2:1)的新结晶形式,以下称为多晶型X,A,B1,B2,C,D和E.本发明还涉及阿托伐他汀的晶型A 对于形成AED杂质是稳定的钙(2:1)。 此外,本发明涉及制备这些结晶形式的方法和包含结晶形式的药物组合物。